您现在的位置: 首页> 研究主题> 白细胞,单核

白细胞,单核

白细胞,单核的相关文献在2001年到2018年内共计65篇,主要集中在内科学、基础医学、肿瘤学 等领域,其中期刊论文65篇、专利文献107241篇;相关期刊29种,包括中国防痨杂志、中国病理生理杂志、中华实验和临床病毒学杂志等; 白细胞,单核的相关文献由332位作者贡献,包括岳亚飞、仲人前、刘映霞等。

白细胞,单核—发文量

期刊论文>

论文:65 占比:0.06%

专利文献>

论文:107241 占比:99.94%

总计:107306篇

白细胞,单核—发文趋势图

白细胞,单核

-研究学者

  • 岳亚飞
  • 仲人前
  • 刘映霞
  • 周伟
  • 孙毅明
  • 张明霞
  • 张树林
  • 张洁云
  • 戴华浩
  • 朱永华
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 王子成; 程立; 吕同德; 苏黎; 林健; 周利群
    • 摘要: 目的:观察炎症因子预处理脂肪干细胞(adipose derived stem cells,ASCs)模拟异常炎症环境能否增强ASCs抑制外周血单个核细胞(peripheral blood mononuclear cells,PBMCs)体外增殖的能力.方法:先用酶消化法对ASCs进行分离及体外培养,流式细胞仪检测其表面CD分子表达情况,用特定培养基诱导分化并鉴定其向脂肪组织和骨组织分化的能力.将PBMCs用CFSE标记后,与炎症因子预处理后的ASCs共培养,对照组无ASCs或使用未经炎症因子处理的ASCs,同时用CD3/CD28刺激PBMCs增殖,最后用流式细胞仪检测PBMC的母代细胞比例,从而判断其增殖情况.结果:ASCs形态为梭形,密集时可成鱼群状生长,可在诱导培养基培养下向脂肪组织和骨组织分化,表面CD分子表达情况与国际脂肪治疗联盟的关于ASCs的说明一致.PBMCs与ASCs体外共培养后,与无ASCs组相比,PBMCs的母代细胞比例有所增加,但效果并不显著,而将PBMCs与用炎症因子预处理后的ASCs共培养,PBMCs的母代细胞比例有明显增加(炎症因子处理后ASCs组38.7%±10%vs.无ASCs组28.4%±8.9%,P<0.05),说明炎症因子预处理的ASCs可明显抑制PBMCs的增殖.结论:炎症因子可增强ASCs的抗炎能力,该发现有助于ASCs更好地在组织修复领域发挥治疗作用.
    • 王克迪; 吕治; 高琰; 贾坤; 苏建荣
    • 摘要: 目的 探讨EBV DNA检测中标本的合理选择.方法 收集2017年1月至6月在北京友谊医院确诊为EB病毒感染的患者,共117例,其中传染性单核粒细胞增多症(IM)44例,EB病毒相关噬血细胞综合征(HLH)36例,移植后淋巴细胞增殖性异常(PTLD)37例,年龄在6个月至28岁.采用实时荧光定量PCR法,定量检测外周血PBMC中和血浆中EBV DNA载量(中位数,四分位数表示),不同标本类型间病毒载量比较采用非参数秩和检验(Mann-Whitney检验),相关性分析采用Spearman相关性分析.结果 IM和PTLD患者PBMC中EBV DNA载量分别为53600(7875,626500)拷贝/ml和114000(3396,590500)拷贝/ml,显著高于血浆中的载量4500(675,8600)拷贝/ml和0(0,0)拷贝/ml,M-W值分别为372.5和30.5,P均0.05.结论 对于EBV感染的诊断与监测,不同疾病推荐的标本类型有所差异,IM和HLH中EBV DNA定量检测推荐采用血浆或血清标本,而PTLD则推荐同时检测PBMC和血浆标本,临床上应根据疾病的种类合理选择标本类型.%Objective To find the rational selection of specimens for the detection of Epstein-Barr virus ( EBV ) DNA.Methods A total of 117 patients were diagnosed with EBV infection at Beijing Friendship Hospital from January to June 2017, including 44 patients with infectious mononucleosis (IM), 36 patients with EBV-associated hemophagocyticlymphohistiocytosis ( HLH ) and 37 patients with post-transplant lymphoproliferative disorders (PTLD).Patients were aged from 6 months to 28 years.EBV DNA loads (median and quartile) in peripheral blood mononuclear cells (PBMC) and plasmawere detected by real-time quantitative PCR.The viral loads of different specimen types were compared by nonparametric rank sum test ( Mann-Whitney test, M-W test) .Spearman correlation analysis was performed for correlation analysis.Results TheEBV DNA loads in PBMC of IM and PTLD were 53600 (7875,626500) copies/ml and 114000 (3396,590500) copies/ml, which were significantly higher than those in plasma [4500 (675, 8600)copies/ml and 0(0, 0)copies/ml, respectively].The M-W values were 372.5 and 30.5 respectively (both P0.05 ) . Conclusions For the diagnosis and monitoring of EBV infection , the types of specimens recommended by different diseases are different .Plasma or serum specimens are recommended for quantitative detection of EBV DNA in IM and HLH, while PBMC and plasma specimens are recommended in PTLD .Clinically, the type of specimen should be chosen reasonably according to the type of disease .
    • 后婕; 齐慧; 戴艳红; 魏先梅; 陆玲; 王俊国; 佘万东
    • 摘要: Objective To investigate the correlation between the proliferation inhibition effect of glucocorticoid (GC) on peripheral blood mononuclear cell (PBMC) and the pure tone average (PTA) improvement in SSNHL patients.Methods Sixty inpatients with SSNHL were included from July 2013 to October 2015 in Nanjing Drum Tower Hospital, Medical School of Nanjing University.Peripheral venous blood was collected before receiving treatment, then the PBMC was isolated for GC proliferation inhibition.PBMCs of each patient were cultivated into 4 groups: Group A: PBMCs+Medium;Group B: PBMCs+Medium+lipopolysaccharide (LPS, 1 μmol/L);Group C: PBMCs+Medium+LPS+Dexamethasone;Group D: Medium.PBMCs were maintained in a humidified 5% CO2 atmosphere at 37°C and were observed after 24 hours.5-diphenyltetrazolium bromide (MTT) was used to measure PBMC proliferation inhibition rate.The PBMC proliferation inhibition rates were calculated according to the absorbance at 490 nm wavelength under a microtiter plate reader.Independent sample t tests of PBMC proliferation inhibition rate were performed between different groups.x2 tests were performed between gender, affected ear side, accompanied by vertigo or not, audiometric curve, time period from onset to treatment, PBMC proliferation inhibition rate and the improvement of pure tone average (PTA).Linear correlation analyses were performed between PBMC proliferation inhibition rate, the time period from onset to treatment and the hearing improvement.Results The proliferation inhibition effect of GC on PBMC varied significantly among patients.The PBMC proliferation inhibition rate in GC insensitive group was lower than that in GC sensitive group (26.72%±21.82% vs 64.44%±25.48%, t=6.113, P0.05).Both in initial group and refractory group, the linear correlation analyses showed a significant positive correlation between PBMC proliferation inhibition rate and the PTA improvement (r value was 0.615, 0.657, respectively, all P0.05).在初诊组和难治组患者中,PTA改善值与PBMC增殖抑制率之间均存在正相关关系(r值分别为0.615、0.657,P值均<0.05),PTA改善值与发病至就诊时间之间均存在负相关关系(r值分别为-0.542、-0.370,P值均<0.05).结论 SSNHL患者的PBMC体外增殖抑制情况与听力预后相关,可用于了解患者对GC的敏感性,为预测预后提供参考.
    • 王晓霖; 黄少军; 邢凌翔; 韩晓颖; 王秀珍; 陈秀记
    • 摘要: 目的 探讨外周血单个核细胞(PBMC) IP-10mRNA水平与HBV相关慢加亚急性肝衰竭患者预后的关系.方法 对2014年1月至2015年2月住院的HBV相关慢加亚急性肝衰竭患者50例,给予内科综合治疗并随访3个月,所有患者抽取外周静脉血检测单个核细胞IP-10mRNA水平;选取同时期20例慢性乙型肝炎(CHB)患者、20例乙肝后肝硬化患者和20例健康体检者作为对照,检测其PBMC中IP-10 mRNA表达水平,分析各组间的差异.同时分析肝衰竭生存组和死亡组IP-10mRNA表达的差异.结果 健康对照组、慢性乙型肝炎组、乙肝后肝硬化组和肝衰竭组患者PBMCIP-10mRNA水平分别为0.412 ±0.061,0.641 ±0.083,0.693±0.033,0.956±0.277.肝衰竭组患者PBMC IP-10mRNA水平显著高于其他三组(P<0.01);慢性乙型肝炎组患者PBMC IP-10mRNA水平高于健康对照组(P<0.01).肝衰竭死亡组PBMC IP-10mRNA水平为1.126±0.270,高于生存组的0.823±0.202,差异有统计学意义(t=-4.5296,P<0.01).受试者工作特征曲线下面积为0.81,临界值为0.9255,大于界值组生存率为18.18% (4/22),小于界值组生存率为85.71%(24/28),x2=22.803,P<0.001.结论 HBV相关慢加急性肝衰竭患者PBMC IP-10mRNA水平与预后相关,检测患者PBMCIP-10mRNA,有助于评估HBV-ACLF的预后.%Objective To study the correlation between the levels of IP-10 mRNA in peripheral blood mononuclear cells (PBMCs) and prognosis of acute-on-chronic hepatitis B virus related liver failure (HBV-ACLF).Methods Fifty patients diagnosed with HBV-ACLF were administered a combined modality therapy and followed up until death or for 3 months.In addition,20 patients with chronic hepatitis B(CHB),20 patients with hepatitis B related cirrhosis and 20 healthy volunteers were matched for use as control.The levels of IP-10 mRNA in PBMCs were detected at baseline and last follow-up visit and compared between groups by statistical analysis.Results At baseline,the CHB group had a significantly higher level of IP-10 mRNA in PBNCs than the healthy control group(t =-6.972,P <0.01).However,the level of IP-10 mRNA in PBMCs of the liver failure group was significantly higher than that of boththe CHB group(t =2.510,P < 0.05) and the healthy control group (t =8.648,P < 0.01).When patients within the liver failure group were divided by survival and death occurring during the 3-month follow-up period,the patients who died were found to have a significantly higher level of IP-10 mRNA in PBMCs than the surviving patients(P < 0.01).The area under the curve of ROC curve is 0.81,and cut off value is 0.9255.Conclusion The level of IP-10 mRNA in PBMCs is positively correlated with risk of death in patients with HBV-ACLF,and its detecting might predict the prognosis of HBV-ACLF.
    • 刘俊文; 刘红春; 苏利沙; 邓少丽; 张根豪; 张俊华; 魏高辉
    • 摘要: 目的:研究IL-21、Blimp1 mRNA在类风湿关节炎( RA)患者体内的表达及IL-21刺激后对体外培养RA患者外周血单个核细胞( PBMCs ) Blimp1表达的影响,探讨IL-21、Blimp1参与RA发病的具体作用机制。方法病例对照研究。收集2012年10月至2013年3月郑州大学第一附属医院住院确诊的RA患者50例和同期健康体检者50名为对照组的外周静脉血,分离血浆及PBMC, ELISA检测血浆IL-21水平,同时检测患者临床指标DAS28和抗环瓜氨酸肽抗体(抗CCP )抗体将其与患者IL-21水平进行相关性分析。实时荧光定量PCR ( qPCR )检测患者PBMC Blimp1 mRNA表达量;分离RA患者PBMCs进行体外培养,经IL-21和CD40L刺激细胞72 h后,检测患者PBMC Blimp1 mRNA表达量,流式细胞术检测各组细胞CD20阳性B细胞和CD138阳性细胞所占比例。采用均值t检验、Wilcoxon秩和检验和方差分析等方法进行统计学分析。结果 RA 患者血清 IL-21水平(130.51±11.35)ng/L明显高于健康对照组(25.46±6.05)ng/L,t=5.39,P=0.007,且IL-21水平与RA患者DAS289(r=0.658)和抗CCP抗体(r=0.674)具有相关性(P分别为0.019、0.016)。 RA患者PBMCs Blimp1 mRNA表达水平(1.321±0.110)高于健康对照组(1.000±0.000),Z=-2.48,P<0.05。 IL-21及CD40L体外刺激后,IL-21组和CD40L+IL-21组Blimp1 mRNA表达量分别为(1.084±0.029)、(1.157±0.028),高于对照组(1.000±0.000),P 分别为0.002、0.001,CD40L +IL-21组Blimp1mRNA表达水平高于IL-21组(t=4.862,P=0.02);CD40L组、IL-21组及IL-21+CD40L组较阴性对照组CD20阳性B细胞比例增加[2.42±0.35、2.63±0.33、6.35(4.85,6.57),F=278.363, P<0.001],CD138阳性细胞所占比例也增加(0.474±0.110、0.668±0.120、0.955±0.170,F =49.01,P<0.001),差异均具有统计学意义。结论 IL-21可促进RA患者外周单个核细胞Blimp1 mRNA的表达;IL-21和CD40L协同作用可能通过调节Blimp1 mRNA的表达促进B细胞的分化成熟进而参与RA的发病。(中华检验医学杂志,2015,38:552-556)%Objective To Investigate the expression of IL-21 and Blimp1 mRNA in Rheumatoid arthritis ( RA) patients and the influence on the expression of Blimp 1 in peripheral blood mononuclear cells (PBMCs) of RA patients after IL-21 stimulated; To further explore the mechanism of IL-21 and blimp1 in the pathogenesis of RA.Methods Case control study.The samples of peripheral venous blood from 50 RA patients of department of rheumatology of The First Affiliated Hospital of Zhengzhou University and 50 healthy people were collected respectively , then the plasma and PBMCs was separated.IL-21 in plasma was measured by ELISA; the correlation between patients clinical index DAS 28, anti-CCP antibody and IL-21 was analyzed.Blimp1 mRNA of patients′PBMCs was detected by qPCR; PMBCs were isolated from RA patient and then cultured in vitro.Blimp1 mRNA level was measured by qPCR and the ratio of CD 20 positive B cell and the ratio of CD138 positive cells in all groups were detected by flow cytometry after 72 h stimulated by IL-21 and CD40L.Results IL-21 content in RA patient blood plasma (130.51 ±11.35)ng/L was significantly higher than that in healthy control (25.46 ±6.05)ng/L, t=5.39,P<0.05.Besides, IL-21 level also had a close relativity with patients DAS28(r=0.658) and anti-CCP antibody (r=0.674, P=0.039 and 0.035).In addition, the expression level of Blimp1 mRNA in RA patient PMBCs (1.321 ± 0.11)was higher than that in healthy control group (1.000 ±0.000), Z=-2.48, P<0.05.While after IL-21 and/or CD40L stimulation, Blimp1 mRNA of IL-21 group and CD40L+IL-21 group(1.084 ±0.029, 1.157 ±0.028)were higher than those of control (1.000 ±0.000)(P=0.002,P=0.001), moreover the expressive level of Blimp1mRNA of CD40L+IL-21 group was higher than that of control group (t=4.862, P=0.02).Compared to negative control group , the ratio of CD20 positive B cells [2.42 ±0.35, 2.63 ± 0.33, 6.35(4.85,6.57),F=278.363,P<0.001] and the ratio of CD138 positive cells(0.474 ±0.110, 0.668 ±0.120, 0.955 ±0.170,F=49.01, P<0.001) in CD40L group, IL-21 group and CD40L+IL-21 group were much higher and the differences among CD 40L+IL-21 group with CD40L group and IL-21 group were statistically significant.Conclusion IL-21 could promote the level of Blimp 1 mRNA in peripheral blood mononuclear cells in RA patient; IL-21 and CD40L could co-promote B cell maturation though regulating Blimp1 mRNA expression and eventually participate in RA pathogenesis.
    • 康玉英; 孙彩虹; 鞠梅; 陈崑; 顾恒
    • 摘要: Objective To study the effects of different stimulators on the production of matrix metalloproteinases (MMPs) by peripheral blood mononuclear cells (PBMCs),and to evaluate the effects of the culture supernatant of activated PBMCs,named conditioned media (CM),on the proliferation of and production of MMPs by cultured human fibroblasts.Methods PBMCs were isolated from the venous blood samples of healthy volunteers and divided into three groups to be stimulated by phytohemagglutinin (PHA group),the combination of antibodies against CD3 and CD28 (double-antibody group),or the RPMI 1640 medium containing 10% fetal calf serum (control group).After 72-hour stimulation,CM was collected from all the three groups,diluted to several different degrees.Cultured human fibroblasts were classified into several groups to be treated with different dilutions of CM from the three groups for 48 or 24 hours,with the fibroblasts untreated with CM serving as the control group.Methyl thiazolyl tetrazolium (MTT) assay was performed to evaluate cellular proliferative activity,semi-quantitative reverse transcription (RT)-PCR to detect the expressions of MMP-1,MMP-3 and MMP-9 mRNAs in cells,and enzyme-linked immunosorbent assay (ELISA) to measure the levels of interleukin (IL)-6,MMP-1,MMP-3 and MMP-9 proteins in the culture supernatant of cells.Statistical analysis was carried out mainly by using one-way analysis of variance (ANOVA),Tukey HSD test,and GamesHowell test.Results Compared with the control group,the PHA group showed increased cellular proliferative activity,IL-6 and MMP-3 protein levels in the culture supernatant of activated PBMCs (all P < 0.05).Significant differences were observed among the PHA group,double-antibody group and control group in the relative mRNA expression level (expressed as the ratio of target mRNA to β-actin mRNA) of MMP-1 in activated PBMCs (0.083 ± 0.016 vs.0.188 ± 0.030 vs.0.714 ± 0.104,F =85.905,P < 0.05),but neither MMP-3 nor MMP-9 mRNA was expressed by activated PBMCs.MMP-3 protein was detectable in the culture supernatant of fibroblasts after the treatment with CM,and the level of MMP-3 protein was highest in that of fibroblasts treated with undiluted CM,and lowest with 1/10 diluted CM;at the same dilutions,the level of MMP-3 protein was highest in the culture supernatant of fibroblasts treated with CM from the PHA group,but lowest with that from the control group.Neither MMP-1 nor MMP-9 protein was detected in the culture supernatant of activated PBMCs or treated fibroblasts.There were no significant differences in cellular proliferative activity of and mRNA expressions of MMP-1 or MMP-3 in fibroblasts among these groups (all P > 0.05),and MMP-9 mRNA expression was undetected in the treated fibroblasts.Conclusions PBMCs can be induced to express MMP-1 mRNA and secret MMP-3 protein after activation.However,the culture supernatant of activated PBMCs has no capacity to stimulate the expressions of MMP-1,MMP-3 and MMP-9 mRNAs or proteins by fibroblasts,suggesting that inflammatory cells may function through self-production of MMPs.%目的 研究不同活化剂对外周血单一核细胞(PBMC)产生基质金属蛋白酶(MMP)的影响以及PBMC活化后培养上清液[称为条件培养基(CM)]对培养的皮肤成纤维细胞增殖活性、产生MMP的影响.方法 抽取、分离健康人PBMC,分为植物血凝素(PHA)组、双抗体组、对照组,分别用活化剂PHA、CD3和CD28双抗体、含10%胎牛血清的RPMI 1640培养基处理细胞,72 h后收集三组CM,并将获得的CM按不同比例稀释后作用于培养的成纤维细胞,以不加CM作为对照组,培养48或24 h.采用噻唑蓝法检测细胞增殖能力,半定量反转录(RT)-PCR法检测细胞MMP-1、MMP-3、MMP-9 mRNA表达水平,酶联免疫吸附实验(ELISA)检测上清液中白介素(IL)-6、MMP-1、MMP-3、MMP-9蛋白含量.采用单因素方差分析、Tukey HSD检验、Games-Howell检验等方法进行统计学分析.结果 与对照组相比,PHA组PBMC增殖活性及分泌IL-6、MMP-3水平明显增加,差异均有统计学意义(P<0.05);3组活化后上清液中均未检测到MMP-1、MMP-9蛋白.对照组、双抗体组、PHA组PBMC中MMP-1 mRNA相对表达水平(以靶基因与β肌动蛋白mRNA之比表示)0.083±0.016、0.188±0.030、0.714土0.104,差异有统计学意义(P<0.05),MMP-3、MMP-9 mRNA均无表达.不同稀释度CM刺激成纤维细胞后上清液中可检测到MMP-3蛋白,MMP-3含量以原液CM中最高,1/10 CM刺激时最低;在相同的稀释度刺激时,上清液中MMP-3含量以PHA刺激组最高,对照刺激组最低;不同CM刺激成纤维细胞后上清液中均未检测到MMP-1、MMP-9蛋白.不同处理组成纤维细胞的增殖能力及MMP-1、MMP-3 mRNA表达差异均无统计学意义(P>0.05),MMP-9 mRNA无表达.结论 PBMC活化后可表达MMP-1 mRNA并分泌MMP-3蛋白,PBMC活化后上清液不能刺激成纤维细胞MMP-1、MMP-3、MMP-9 mRNA及蛋白表达,提示炎症细胞可能通过自身产生MMP而发挥作用.
    • 何免; 邱小惠; 张文峰; 沈晗; 王辉; 薄华本; 黄树林; 曾宪成; 邵红伟
    • 摘要: 目的:探讨杀伤细胞免疫球蛋白样受体(KIR)基因在肝癌细胞免疫杀伤中的作用。方法外周血单个核细胞(PBMC)与肝癌细胞HepG2按不同效靶比共孵育,观察不同效靶比共孵育下PBMC中KIR基因家族的表达、γ干扰素(IFN-γ)分泌、肝癌细胞形态学改变及PBMC对肝癌细胞的杀伤情况。杀伤率比较采用单因素方差分析和LSD-t检验。结果与肝癌细胞共孵育12 h后PBMC活化性KIR基因表达开始增加,24 h后下降。抑制性KIR基因共孵育12 h后开始下降。辅助活化基因DAP12一直保持高表达水平。PBMC中IFN-γ的含量随着效靶比的升高而降低,12 h达到高峰。共孵育后不同效靶比组的肝癌细胞均表现为染色质浓缩,细胞核呈半球状或半月形状且边缘化的细胞比例增加,细胞停止旺盛分裂。效靶比1∶1组的相对杀伤率为(8±3)%,10∶1组为(14±4)%,50∶1组为(32±6)%,50∶1组明显高于1∶1组和10∶1组(LSD-t=5.97,4.61;P<0.05)。结论活化性KIR基因在肝癌细胞免疫杀伤中发挥重要作用。%ObjectiveTo investigate the effect of killer cell immunoglobulin-like receptor (KIR) gene in immune killing of hepatoma cells.MethodsPeripheral blood mononuclear cell (PBMC) and hepatoma cells were co-cultured with different effector-target ratios. The expression of KIR gene family in PBMC, the content to interferon-γ (IFN-γ), the morphological change of hepatoma cell and the cytotoxicity to hepatoma cell by PBMC were observed after the co-incubation with different effector-target ratios. The comparison on cytotoxicity rates was conducted using one-way analysis of variance and LSD-t test.ResultsThe expression of activating KIR gene increased after 12 h of co-culture, but decreased after 24 h of co-culture. The expression of inhibitory KIR gene decreased after 12 h of co-culture. DAP12 maintained high expression all the time. The content of IFN-γ in PBMC decreased with the increase of effector-target ratio and reached the peak at 12 h of co-culture. Hepatoma cells co-cultured with different effector-target ratios were observed with increased chromatin condensation, rising proportion of cells with hemispherical or half moon shape and marginalized nucleus, and stagnant of active cell division. The cytotoxicity rate of effector-target ratio 1∶1, 10∶1 and 50∶1 was (8±3) %, (14±4) % and (32±6) %, respectively, with 50∶1 group significantly higher than 11∶1 and 10∶1 group (LSD-t=5.97, 4.61;P<0.05).ConclusionThe activating KIR gene plays an important role in immune killing of hepatoma cells.
    • 赵美芬; 刘映霞; 彭忠田; 陈川铁; 刘京; 林益敏; 陈建波
    • 摘要: 目的 研究外周血浆细胞分泌特异性结核分枝杆菌抗体对活动性结核病的诊断价值.方法 纳入2013年4月至7月期间深圳市第三人民医院肺科门诊活动性结核病患者;健康对照组人员来自体检科门诊志愿者,分为3个组:活动性结核病组(104例)、结核分枝杆菌(Mtb)潜伏感染组(26例)和健康对照组(33名).分离其外周血单个核细胞(PBMCs).体外培养4d后收集培养上清液,用ELISA法和蛋白免疫印迹法,ELISA和蛋白免疫印迹法检测外周血浆细胞分泌的特异性结核分枝杆菌抗体;检测各组收集的PBMCs培养上清液中的特异性结核分枝杆菌抗体,比较各组间的差异.所有数据均使用GraphPad Prism 5.0进行统计学分析,用受试者工作特征(ROC)曲线评价ELISA法检测的诊断价值,得出敏感度、特异度;多组间的比较采用Kruskal Wallis检验;两组间比较采用Dunn multiple comparison检验;蛋白免疫印迹法用四格表的卡方检验;以P<0.05为差异有统计学意义.结果 ELISA法检测活动性结核病组特异性结核分枝杆菌抗体的A450nm值(0.593±0.206)高于Mtb潜伏感染组(0.342±0.152)和健康对照组(0.246±0.121),差异有统计学意义(H=77.27,P<0.001).特异性结核分枝杆菌抗体区分活动性结核病患者和Mtb潜伏感染者、健康对照者曲线下面积(AUC)分别为0.857、0.944,当诊断界限值为0.42时,其区分活动性结核病和Mtb潜伏感染的敏感度为77.9%(81/104),特异度为80.8%(21/26);区分活动性结核病和健康人的敏感度为77.9%(81/104),特异度为93.9%(31/33).蛋白免疫印迹法检测活动性结核病和健康人的敏感度、特异度和准确性分别为79.2%(61/77)、100.0%(11/11)、81.8% (72/88)(x2 =24.8,P<0.001).结论 ELISA法和蛋白免疫印迹法检测外周血浆细胞分泌特异性结核分枝杆菌抗体诊断活动性结核病特异度高,可以作为临床结核病实验诊断的辅助方法.
    • 蒋俊
    • 摘要: 近几年来,结核分枝杆菌感染T细胞斑点试验(T-SPOT.TB)在国内外已较多地应用于结核分枝杆菌感染检测或相关性研究.T-SPOT.TB作为集细胞生物学和免疫学检测技术为一体的新方法,虽然操作并不复杂,但对试验条件、操作技术和质量控制要求很高,其试验体系中外周血单个核细胞(PBMCs)的分离、加入活体细胞的数量、细胞孵育条件和结果判定等的全程质量控制,既是决定试验成败的关键,又是常常易于忽略的“潜在性”问题.作者依据其试验原理和临床实践对试验中常见的PBMCs分离呈现的不同状态进行了分析和描述;对PBMCs的分离、悬液制备、体外孵育和结果判定的质量控制进行了重点论述,其中就人工PBMCs计数误差对试验结果的影响进行了详细阐述.除此,还依据传统的改良牛鲍血细胞计数板白细胞计数法和溶液浓度稀释法溶液浓度与体积成反比的基本原理,结合活体PBMCs计数和标准细胞悬液终浓度2.5×105/100μl的特殊要求,建立了简易的细胞计数“一步法”和“计算式”,使标准细胞悬液的制备趋于简化.
    • 梁冬雨; 高得勇; 娄晓丽; 侯彦强
    • 摘要: Objective To evaluate the expression and clinical significance of miRNA in plasma of patients with primary biliary cirrhosis.Methods Plasma from 19 PBC patients,10 healthy volunteers and 10 viral hepatitis patients were selected from Shanghai Songjiang Hospital from december 2010 to January 2013.Among them 3 PBC patients' plasma and 3 healthy volunteers' plasma were detected by miRNA microarray for miRNA expression profile examination.Real-time PCR was used to verify the results of microarray,miRNA target gene predictior software was used to predict the target genes of differentially expressed miRNA.ROC was used to determine the clinical value of plasma miRNA.Results According to microarray,a total of 16 miRNAs were found to be differentially expressed.As revealed by qRT-PCR,the expression of miRNA-92a-3p and miRNA-4516 decreased while the expression of miRNA-572 and miRNA-575 were up-regulated in PBC group compared with healthy controls (P < 0.05).In comparison with nonPBC cirrhosis group,only miRNA-92a-3p and miRNA-4516 were down-regulated (P < 0.05).The area under the curve (AUC)of miRNA-92a-3p for the diagnosis and differential diagnosis of PBC were 0.92 and 0.84,respectively.while for The area under the ROC curve of miRNA-4516,the AUC for diagnosis and differential diagnosis PBC were 0.89 and 0.76,respectively.The optimal cut-off values for identifying PBC from healthy controls were defined as 1.26 ng/μl.for miRNA-92a-3p (sensitivity,92% ;specificity,80%)and 1.16ng/ul for miRNA-4516 (sensitivity,85% ;specificity,70%)respectively.The optimal cut-off values for identifying PBC from viral hepatitis were defined as 1.08 ng/μl.for miRNA-92a-3p (sensitivity,89% ; specificity,81%)and 1.06 ng/μl for miRNA-4516 (sensitivity,77% ;specificity,68%).Conclusion The results indicate that plasma from patients with PBC has a unique miRNA exprssion profile and these differentially expressed miRNA can be used as clinical biomarkers of PBC.%目的 探讨原发性胆汁性肝硬化(PBC)患者血浆微小RNA(miRNA)的表达及临床意义.方法 采用随机对照研究的方法,收集上海松江中心医院2010年12月至2013年1月就诊的19例PBC患者的血浆,同时收集了性别年龄与PBC患者相匹配的10名健康体检者和10例病毒性肝炎患者的血浆,从中选取3例PBC患者和3名健康体检者,应用芯片技术进行miRNA表达谱筛选.针对筛选出有表达差异的miRNA,采用荧光定量PCR(qRT-PCR)技术对收集的3组标本进行验证,统计学分析和绘制受试者工作曲线(ROC)评估差异miRNA的临床价值.结果 芯片结果显示PBC组与对照组共有16个差异表达miRNA.qRT-PCR验证发现,与正常组相比,PBC组miRNA-572和miRNA-575表达明显上调(P<0.05),miRNA-92a-3p和miRNA-4516表达明显下调(P<0.05).而与非PBC肝硬化组相比,PBC组miRNA-92a-3p和miRNA-4516表达下调(P<0.05).miRNA-92a-3p在评价PBC组和健康对照组的曲线下面积(AUC)为0.92(0.86~ 1.00),当最佳临界值为1.26,敏感度92%,特异度80%.miRNA-4516在评价PBC组和健康对照组的曲线下面积为0.89(0.75 ~1.00),当最佳临界值为1.16,敏感度85%,特异度70%.miRNA-92a-3p和miRNA-4516在鉴别诊断PBC和非PBC肝硬化时曲线下面积分别为0.84 (0.68~0.99)和0.76(0.57 ~0.96).当miRNA-92a-3p取最佳临界值为1.08,敏感度89%,特异度81%.当miRNA-4516取最佳临界值为1.06,敏感度77%,特异度68%.结论 PBC患者血浆中特异表达的miRNA对PBC诊断及鉴别诊断的具有潜在临床应用价值.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号